Publication:
Severe creatine kinase increase during quetiapine and mirtazapine treatment

Simple item page
dc.contributor.authorRABUŞ, ŞULE
dc.contributor.authorsRabus, SA; Izzettin, F; Rabus, M; Bilici, M
dc.date.accessioned2022-04-25T00:10:20Z
dc.date.available2022-04-25T00:10:20Z
dc.date.issued2006
dc.description.abstractIn the literature, there have been several publications reporting creatine kinase (CK) increases associated with the use of atypical antipsychotic drugs. In this letter, I would like to present a case in which there was a massive increase in serum CK levels together with relatively modest increases in serum CK myoglobin-band (CK-MB), lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels during quetiapine and mirtazapine treatment, without the presence of neuroleptic malignant syndrome (NMS).
dc.identifier.doi10.1007/s00213-005-0273-3
dc.identifier.issn0033-3158
dc.identifier.pubmed16374598
dc.identifier.urihttps://hdl.handle.net/11424/263656
dc.identifier.wosWOS:000235914100015
dc.languageeng
dc.publisherSPRINGER
dc.relation.ispartofPSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectANTIPSYCHOTIC-DRUGS
dc.subjectOLANZAPINE
dc.subjectELEVATIONS
dc.subjectCLOZAPINE
dc.titleSevere creatine kinase increase during quetiapine and mirtazapine treatment
dc.typeother
dc.type.subletter
dspace.entity.typePublication
local.avesis.ida9ce7cb1-5759-42ca-8487-6a2c9fd1f1ab
local.import.packageSS39
local.indexed.atWOS
local.journal.numberofpages2
oaire.citation.endPage264
oaire.citation.issue2
oaire.citation.startPage263
oaire.citation.titlePSYCHOPHARMACOLOGY
oaire.citation.volume185
relation.isAuthorOfPublication1dca99df-cdec-44eb-bf0f-a270bdf48f9e
relation.isAuthorOfPublication.latestForDiscovery1dca99df-cdec-44eb-bf0f-a270bdf48f9e

Files

Collections

Research Outputs